Skip to main content
Clinical Trials/NL-OMON39343
NL-OMON39343
Not yet recruiting
Phase 4

Magnetic Resonance Imaging to diagnose endometriosis using Ablavar ® as contrast agent - a feasibility study - Ablavar ® in endometriosis diagnosis

Medisch Universitair Ziekenhuis Maastricht0 sites5 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
endometriosis
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
5
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • Older that 18 years;
  • Suspect of peritoneal endometriosis, palpable nodule at physical examination;
  • Patient planned for MRI and laparoscopic treatment of the disease;
  • Pre menopausal;
  • Using contraception during the time of the study;
  • Willing and able to undergo all study procedures;
  • written informed consent.

Exclusion Criteria

  • Pregnancy / breast feeding;
  • Post menopausal status or under GnRH analogue treatment;
  • Patients presenting with a contraindication to MRI such as pacemaker, aneurysm clip, severe claustrophobia or ferromagnetic implants;
  • Impaired kidney function (estimated Glomerular Filtration Rate, eGFR \< 60\) or acute kidney injury;
  • History of severe allergic reaction or allergic reaction to MR contrast media;
  • Allergy (hypersensitivity) to any of the ingredients of Ablavar ®;
  • Being unable to give informed consent in person.

Outcomes

Primary Outcomes

Not specified

Similar Trials